David Knechtel is the Vice President and General Manager at argenx, leading the launch of efgartigimod in Europe. With extensive experience in pharmaceutical companies like Otsuka and Johnson & Johnson across Europe and the UK, David has a strong background in sales, marketing, and business development. David holds an MBA from Duke University, emphasizing in Health Sector Management.
This person is not in the org chart
This person is not in any offices